Glytec announced today that it entered into a strategic partnership with Roche Diagnostics USA for a digital health collaboration.
Waltham, Massachusetts-based Glytec’s partnership combines its FDA-cleared Glucommander insulin dosing decision support software with Roche’s expertise in medical devices and IT solutions in an effort to address the challenges associated with inpatient blood sugar management at the hospital bedside.
Get the full story at our sister site, Drug Delivery Business News.